Bausch + Lomb Deal History & Licensing Activity
Bausch + Lomb is a large pharma headquartered in Canada. The company currently has 19 active clinical trials.
Deals (12mo)
1
Active Trials
19
Top Modality
N/A
Focus Area
N/A
Bausch + Lomb Strategic Signals
Key indicators of Bausch + Lomb's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Strategic Priorities
Bausch + Lomb Clinical Pipeline
Bausch + Lomb has 19 active clinical trials across 5 development phases.
4
Unknown
9
Not Applicable
2
Phase 4
1
Phase 1
3
Phase 2
See How Your Asset Matches Bausch + Lomb's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
About Bausch + Lomb Licensing & Deal Activity
Bausch + Lomb is a large pharma company based in Canada that has been actively engaged in licensing transactions across the biopharma landscape.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Bausch + Lomb and 700+ other biopharma companies. Use our Solidus to benchmark your asset against Bausch + Lomb's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.